Journal of Neural Transmission

, Volume 119, Issue 5, pp 621–626 | Cite as

Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette’s syndrome

  • Yuval Eliahu Landau
  • Tamar Steinberg
  • Brian Richmand
  • James Frederick Leckman
  • Alan Apter
Biological Child and Adolescent Psychiatry - Original Article

Abstract

Tourette’s syndrome is a neurodevelopmental disorder clinically characterized by multiple motor and phonic tics. It is likely that a neurobiological susceptibility to the disorder is established during development by the interaction of genetic, biochemical, immunological, and environmental factors. This study sought to investigate the possible correlation of several immunological and biochemical markers with Tourette’s syndrome. Children with Tourette’s syndrome attending a tertiary pediatric medical center from May 2008 to April 2010, and healthy age-matched control subjects underwent a comprehensive biochemical and immunological work-up. Demographic data were abstracted from the medical records. Findings were compared between the groups and analyzed statistically. Sixty-eight children with Tourette’s syndrome (58 males, 85.3%) and 36 healthy children (25 males, 69.4%) were recruited. Compared with the control group, the Tourette’s syndrome group had significantly higher levels of ferritin (p = 0.01) and hemoglobin (p = 0.02), a lower level of zinc (p = 0.05), and a lower percentage of non-ceruloplasmin copper (p = 0.01). Analysis of the immunological markers revealed no significant between-group differences in IgA, IgM or IgG; however, IgE and IgG-4 levels were significantly higher in the Tourette’s syndrome group (p = 0.04 and p = 0.02, respectively). Children with Tourette’s syndrome have high levels of biochemical indices of oxidative stress and the quantitative immunoglobulins. These findings add to the still-limited knowledge on the pathogenesis of Tourette’s syndrome and may have implications for the development of novel therapeutic modalities.

Keywords

Tourette syndrome Oxidative stress Heavy metals metabolism Autoimmunity Immunoglobulins 

Notes

Acknowledgments

The authors thank Pearl Lilos of the Department of Statistics, Schneider Children’s Medical Center of Israel, Tel Aviv University, for the statistical analysis of the data.

Conflict of interest

Authors Y. E. Landau, T. Steinberg, and A. Apter declare that they have no conflicts of interest. B. Richmand: the funding for this study was provided by Brian and Linda Richmand, and Scott and Amy Horwitz. J. F. Leckman: support for the past three years: NIH (salary and research funding), Tourette Syndrome Association (research funding), Talecris Biotherapeutics (research funding), Klingenstein Third Generation Foundation (medical student fellowship program), John Wiley and Sons (book royalties), McGraw Hill (book royalties), Oxford University Press (book royalties).

References

  1. Bos-Veneman NG, Olieman R, Tobiasova Z, Hoekstra PJ, Katsovitch L, Bothwell AL et al (2010) Altered immunoglobulin profiles in children with Tourette syndrome. Brain Behav Immun 25:532–538PubMedCrossRefGoogle Scholar
  2. Budman C, Sarcevic A (2002) An unusual case of motor and vocal tics with obsessive–compulsive symptoms in a young adult with Behcet’s syndrome. CNS Spectr 7:878–881PubMedGoogle Scholar
  3. Crayton JW, Walsh WJ (2007) Elevated serum copper levels in women with a history of post-partum depression. J Trace Elements Med Biol 21:17–21CrossRefGoogle Scholar
  4. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress. J Neurol Sci 143:137–142PubMedCrossRefGoogle Scholar
  5. Finegold I (1985) Allergy and Tourette’s syndrome. Ann Allergy 55:119–121PubMedGoogle Scholar
  6. Gorman DA, Zhu H, Anderson GM, Davies M, Peterson BS (2006) Ferritin levels and their association with regional brain volumes in Tourette’s syndrome. Am J Psych 163:1264–1272CrossRefGoogle Scholar
  7. Hamilton CS, Garvey MA, Swedo SE (2001) Therapeutic implications of immunology for tics and obsessive–compulsive disorder. In: Cohen DJ, Jankovic J, Goetz CG (eds) Advances in neurology. Tourette syndrome, vol 85. Lippincott Williams and Wilkins, Philadelphia, pp 311–318Google Scholar
  8. Hsieh MY, Lee WI, Lin KL, Hung PC, Chou ML, Chang MY et al (2010) Immunologic analysis and serum heavy metal levels in exacerbated Tourette syndrome. Pediatr Allergy Immunol 21:e768–e771CrossRefGoogle Scholar
  9. Hultberg M, Isaksson A, Andersson A, Hultberg B (2007) Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content. Chem Biol Interact 167:56–62PubMedCrossRefGoogle Scholar
  10. Jankovic J (2001) Tourette’s syndrome. NEJM 345:1184–1192PubMedCrossRefGoogle Scholar
  11. Kiessling LS, Marcotte AC, Culpepper L (1993) Antineuronal antibodies in movement disorders. Pediatrics 92:39–43PubMedGoogle Scholar
  12. Kurlan R (2010) Tourette’s syndrome. NEJM 363:2332–2338PubMedCrossRefGoogle Scholar
  13. Kushner HI (1999a) A cursing brain? The histories of Tourette syndrome. Harvard University Press, CambridgeGoogle Scholar
  14. Kushner HI (1999b) From Gilles de la Tourette’s disease to Tourette syndrome: a history. CNS Spectr 4:24–35Google Scholar
  15. Leckman JF (2002) Tourette’s syndrome. Lancet 360:1577–1586PubMedCrossRefGoogle Scholar
  16. Leckman JF, Cohen DJ, Goetz CG, Jankovic J (2001) Tourette syndrome: pieces of the puzzle. In: Cohen DJ, Jankovic J, Goetz CG (eds) Advances in neurology. Tourette syndrome, vol 85. Lippincott Williams and Wilkins, Philadelphia, pp 369–390Google Scholar
  17. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF (2009) Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord 24:1267–1279PubMedCrossRefGoogle Scholar
  18. Mezaki T, Matsumoto S, Hamada C, Mukoyama I, Sakamoto T, Mizutani K et al (2001) Decreased serum ceruloplasmin and copper levels in cervical dystonia. Ann Neurol 49:138–139PubMedCrossRefGoogle Scholar
  19. Morselli-Labate AM, Pezzilli R (2009) Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol 24:15–36PubMedCrossRefGoogle Scholar
  20. Murphy TK, Kurlan R, Leckman J (2010) The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 20:317–331PubMedCrossRefGoogle Scholar
  21. Najim RA, Sharquie KE, Abu-Raghif AR (2007) Oxidative stress in patients with Behcet’s disease: I correlation with severity and clinical parameters. J Dermatol 34:308–314PubMedCrossRefGoogle Scholar
  22. Nomoto N (2004) Inhibitory effect of free radical scavenger, MCI-186, in the increase of hydroxyl radical induced by iminodipropionitrile in rats. J Neurol Sci 219:41–44PubMedCrossRefGoogle Scholar
  23. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL et al (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153–1158PubMedCrossRefGoogle Scholar
  24. Peterson BS, Gore JC, Riddle MA, Cohen DJ, Leckman JF (1994) Abnormal magnetic resonance imaging T2 relaxation time asymmetries in Tourette’s syndrome. Psych Res Neuroimag 55:205–221CrossRefGoogle Scholar
  25. Robertson M, Evans K, Robinson A, Trimble M, Lascelles P (1987) Abnormalities of copper in Gilles de la Tourette syndrome. Biol Psychiatry 22:968–978PubMedCrossRefGoogle Scholar
  26. Smith MA (2006) Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! J Alzheimers Dis 9:305–308PubMedGoogle Scholar
  27. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF (2007) Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry 46:947–968PubMedCrossRefGoogle Scholar
  28. Tagawa A, Ono S, Shibata M, Imai T, Suzuki M, Shimizu N (2001) A new neurological entity manifesting as involuntary movements and dysarthria with possible abnormal copper metabolism. J Neurol Neurosurg Psychiatry 71:780–783PubMedCrossRefGoogle Scholar
  29. Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K (2010) The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 9:591–594PubMedCrossRefGoogle Scholar
  30. Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA (2007) Oxidant/antioxidant status in men with Behcet’s disease. Clin Rheumatol 26:418–422PubMedCrossRefGoogle Scholar
  31. Twomey PJ, Viljoen A, House I, Reynolds T, Wierzbicki A (2006) Adjusting copper concentrations for caeruloplasmin in routine clinical practice. J Clin Pathol 59:867–869PubMedCrossRefGoogle Scholar
  32. Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S et al (2007) Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J Biol Chem 282:4364–4372PubMedCrossRefGoogle Scholar
  33. Yao Y, Walsh WJ, McGinnis WR, Pratico D (2006) Altered vascular phenotype in autism: correlation with oxidative stress. Arch Neurol 63:1161–1164PubMedCrossRefGoogle Scholar
  34. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ (2005) Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 166:1681–1690PubMedCrossRefGoogle Scholar
  35. Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A et al (2007) Vascular oxidative stress in Alzheimer disease. J Neurol Sci 257:240–246PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Yuval Eliahu Landau
    • 1
  • Tamar Steinberg
    • 1
  • Brian Richmand
    • 2
  • James Frederick Leckman
    • 3
  • Alan Apter
    • 1
  1. 1.The Freund Tourette Syndrome Clinic, Department of Psychological Medicine, and Department of Child Development and NeurologySchneider Children’s Medical Center of Israel, Tel Aviv UniversityPetah TiqwaIsrael
  2. 2.The Richmand Foundation for the Study of Pediatric Autoimmune Neuropsychiatric and Developmental Disorders, LtdChappaquaUSA
  3. 3.Child Study Center and the Departments of Pediatrics and PsychologyYale University School of MedicineNew HavenUSA

Personalised recommendations